IN2013MU03508A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03508A IN2013MU03508A IN3508MU2013A IN2013MU03508A IN 2013MU03508 A IN2013MU03508 A IN 2013MU03508A IN 3508MU2013 A IN3508MU2013 A IN 3508MU2013A IN 2013MU03508 A IN2013MU03508 A IN 2013MU03508A
- Authority
- IN
- India
- Prior art keywords
- linezolid
- present
- crystalline form
- relates
- crystallizing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3508MU2013 IN2013MU03508A (de) | 2013-11-06 | 2014-11-06 | |
PCT/IB2014/065837 WO2015068121A1 (en) | 2013-11-06 | 2014-11-06 | Process for preparation of crystalline form i of linezolid and its compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3508MU2013 IN2013MU03508A (de) | 2013-11-06 | 2014-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03508A true IN2013MU03508A (de) | 2015-07-24 |
Family
ID=52144768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3508MU2013 IN2013MU03508A (de) | 2013-11-06 | 2014-11-06 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2013MU03508A (de) |
WO (1) | WO2015068121A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105566242B (zh) * | 2016-01-12 | 2017-12-05 | 江苏豪森药业集团有限公司 | 利奈唑胺及其中间体的制备方法 |
CN110483431A (zh) * | 2019-09-04 | 2019-11-22 | 桂林南药股份有限公司 | 利奈唑胺杂质化合物、其制备方法以及其应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
WO1999024393A1 (en) | 1997-11-07 | 1999-05-20 | Pharmacia & Upjohn Company | Process to produce oxazolidinones |
US6444813B2 (en) | 2000-02-02 | 2002-09-03 | Pharmacia & Upjohn Company | Linezolid-crystal form II |
ES2331454T1 (es) | 2003-10-16 | 2010-01-05 | Symed Labs Limited | Forma cristalina de linezolid. |
WO2006110155A1 (en) | 2004-06-29 | 2006-10-19 | Teva Pharmaceutical Industries Ltd | Solid forms of linezolid and processes for preparation thereof |
US7649096B2 (en) | 2005-07-15 | 2010-01-19 | Glenmark Pharmaceuticals Limited | Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide |
WO2007026369A1 (en) | 2005-08-29 | 2007-03-08 | Symed Labs Limited | A novel amorphous form of linezolid |
US20070197529A1 (en) | 2005-12-01 | 2007-08-23 | Viviana Braude | Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
CN101774978B (zh) | 2009-01-13 | 2011-09-21 | 联化科技股份有限公司 | 一种利奈唑胺的制备方法及其中间体 |
WO2011050826A1 (en) | 2009-10-28 | 2011-05-05 | Synthon B.V. | Process for making crystalline form a of linezolid |
US20130137864A1 (en) | 2009-12-26 | 2013-05-30 | Jayaraman Venkat Raman | Process for the preparation of linezolid |
EP2603505A1 (de) | 2010-08-11 | 2013-06-19 | Synthon BV | Verfahren zur herstellung von linezolid |
EP2593440A1 (de) | 2011-02-24 | 2013-05-22 | Lee Pharma Limited | Kristalline form ii von wasserfreiem linezolid |
WO2012119653A1 (en) | 2011-03-09 | 2012-09-13 | Synthon Bv | Process for making crystalline form a of linezolid |
WO2013072923A1 (en) | 2011-09-19 | 2013-05-23 | Cadila Healthcare Limited | Process for the preparation of crystalline linezolid |
WO2013093751A1 (en) | 2011-12-24 | 2013-06-27 | Alembic Pharmaceuticals Limited | Packaging for linezolid |
WO2013120496A1 (en) | 2012-02-14 | 2013-08-22 | Pharmathen S.A. | Process for the preparation of linezolid in crystalline form and salts thereof |
CN102850290A (zh) | 2012-10-10 | 2013-01-02 | 天津市炜杰科技有限公司 | 晶型i型利奈唑胺的制备方法 |
WO2014101064A1 (zh) * | 2012-12-27 | 2014-07-03 | 上海创诺医药集团有限公司 | 一种制备利奈唑胺晶型i的方法 |
-
2014
- 2014-11-06 WO PCT/IB2014/065837 patent/WO2015068121A1/en active Application Filing
- 2014-11-06 IN IN3508MU2013 patent/IN2013MU03508A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015068121A1 (en) | 2015-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021014128A (es) | Polimorfos de selinexor. | |
JO3675B1 (ar) | مشتقات هيدروكسي إستر جديدة،عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
IN2015KN00262A (de) | ||
MX2016012419A (es) | Formas solidas de ibrutinib y procesos para la produccion de las mismas. | |
PH12014000179A1 (en) | New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them | |
EA033455B1 (ru) | Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе | |
HK1220965A1 (zh) | 鹽、相關的晶體形式、其製備方法以及含有其的藥物組合物 | |
MX2015009617A (es) | Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico. | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
IN2014MU00455A (de) | ||
MY191352A (en) | Aldosterone synthase inhibitors | |
MX362858B (es) | Proceso para la preparacion de pemetrexed y sal de lisina del mismo. | |
MX2016009667A (es) | Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma. | |
PH12018500872A1 (en) | Innovative preparation and crystallization of iosimenol | |
IN2013MU03508A (de) | ||
MX359887B (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
IL245260A0 (en) | Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof | |
TN2015000095A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
IN2013CH04314A (de) | ||
IN2013MU02528A (de) | ||
MX2020009412A (es) | Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido. | |
IN2013MU02133A (de) | ||
IN2013MU02771A (de) | ||
MX2016011288A (es) | Crisol hibrido para cristalizar materiales. | |
MX2016001100A (es) | Proceso mejorado para preparar la forma cristalina iv del posaconazol. |